Integra LifeSciences (IART) Competitors $13.11 +0.40 (+3.15%) Closing price 04:00 PM EasternExtended Trading$13.12 +0.01 (+0.04%) As of 04:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IART vs. ATEC, ATRC, SRDX, OFIX, ANGO, ARAY, RMTI, RSLS, ABT, and ISRGShould you be buying Integra LifeSciences stock or one of its competitors? The main competitors of Integra LifeSciences include Alphatec (ATEC), AtriCure (ATRC), Surmodics (SRDX), ORTHOFIX MEDICAL (OFIX), AngioDynamics (ANGO), Accuray (ARAY), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), and Intuitive Surgical (ISRG). These companies are all part of the "health care equipment" industry. Integra LifeSciences vs. Its Competitors Alphatec AtriCure Surmodics ORTHOFIX MEDICAL AngioDynamics Accuray Rockwell Medical ReShape Lifesciences Abbott Laboratories Intuitive Surgical Integra LifeSciences (NASDAQ:IART) and Alphatec (NASDAQ:ATEC) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, valuation, analyst recommendations, profitability, media sentiment and earnings. Is IART or ATEC more profitable? Integra LifeSciences has a net margin of -1.78% compared to Alphatec's net margin of -25.77%. Integra LifeSciences' return on equity of 12.12% beat Alphatec's return on equity.Company Net Margins Return on Equity Return on Assets Integra LifeSciences-1.78% 12.12% 4.58% Alphatec -25.77%-1,657.19%-21.53% Do institutionals & insiders have more ownership in IART or ATEC? 84.8% of Integra LifeSciences shares are owned by institutional investors. Comparatively, 66.4% of Alphatec shares are owned by institutional investors. 3.5% of Integra LifeSciences shares are owned by company insiders. Comparatively, 20.9% of Alphatec shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has more volatility & risk, IART or ATEC? Integra LifeSciences has a beta of 1.15, indicating that its share price is 15% more volatile than the S&P 500. Comparatively, Alphatec has a beta of 1.05, indicating that its share price is 5% more volatile than the S&P 500. Do analysts recommend IART or ATEC? Integra LifeSciences currently has a consensus price target of $18.63, indicating a potential upside of 42.07%. Alphatec has a consensus price target of $18.13, indicating a potential upside of 67.51%. Given Alphatec's stronger consensus rating and higher possible upside, analysts clearly believe Alphatec is more favorable than Integra LifeSciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Integra LifeSciences 4 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.78Alphatec 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89 Which has better valuation & earnings, IART or ATEC? Integra LifeSciences has higher revenue and earnings than Alphatec. Integra LifeSciences is trading at a lower price-to-earnings ratio than Alphatec, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIntegra LifeSciences$1.61B0.63-$6.94M-$0.38-34.50Alphatec$611.56M2.59-$162.12M-$1.15-9.41 Does the media favor IART or ATEC? In the previous week, Integra LifeSciences and Integra LifeSciences both had 5 articles in the media. Integra LifeSciences' average media sentiment score of 0.86 beat Alphatec's score of 0.14 indicating that Integra LifeSciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integra LifeSciences 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Alphatec 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral SummaryIntegra LifeSciences beats Alphatec on 9 of the 15 factors compared between the two stocks. Get Integra LifeSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IART and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IART and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IART vs. The Competition Export to ExcelMetricIntegra LifeSciencesMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.02B$7.00B$5.74B$9.51BDividend YieldN/A1.28%4.60%3.99%P/E Ratio-34.5025.5128.1120.03Price / Sales0.6366.31461.37103.88Price / Cash2.8820.6736.5559.01Price / Book0.654.758.655.90Net Income-$6.94M$176.14M$3.25B$258.66M7 Day Performance17.79%2.92%4.21%2.22%1 Month Performance10.45%3.56%10.82%12.76%1 Year Performance-58.42%7.66%34.70%19.36% Integra LifeSciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IARTIntegra LifeSciences4.1232 of 5 stars$13.11+3.1%$18.63+42.1%-59.5%$1.02B$1.61B-34.504,396News CoverageUpcoming EarningsATECAlphatec3.904 of 5 stars$10.91-0.7%$17.89+64.0%-1.8%$1.59B$642.27M-9.49700Upcoming EarningsATRCAtriCure3.3291 of 5 stars$31.30+1.9%$50.67+61.9%+25.8%$1.55B$480.08M-38.641,300Positive NewsUpcoming EarningsSRDXSurmodics4.0139 of 5 stars$31.39+1.7%$43.00+37.0%-23.3%$448.88M$126.08M-22.58450Positive NewsUpcoming EarningsOFIXORTHOFIX MEDICAL2.744 of 5 stars$10.98-0.6%$21.50+95.8%-33.6%$430.20M$799.49M-2.981,616Positive NewsANGOAngioDynamics3.9183 of 5 stars$9.63+3.3%$14.00+45.4%+24.3%$391.05M$283.32M-9.53760High Trading VolumeARAYAccuray3.0175 of 5 stars$1.36flatN/A-29.4%$140.10M$465.25M0.001,040Positive NewsRMTIRockwell Medical3.9884 of 5 stars$1.11-1.8%$4.00+260.4%-40.9%$37.93M$97.73M0.00300Positive NewsRSLSReShape Lifesciences0.4283 of 5 stars$2.39+0.4%N/A-99.1%$5.71M$8.01M-0.0150Positive NewsABTAbbott Laboratories4.9902 of 5 stars$132.05+0.0%$143.11+8.4%+17.2%$229.74B$42.34B17.13114,000ISRGIntuitive Surgical4.6935 of 5 stars$516.44+0.9%$592.86+14.8%+7.6%$185.10B$8.35B75.7215,638Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision Related Companies and Tools Related Companies ATEC Alternatives ATRC Alternatives SRDX Alternatives OFIX Alternatives ANGO Alternatives ARAY Alternatives RMTI Alternatives RSLS Alternatives ABT Alternatives ISRG Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IART) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Integra LifeSciences Holdings Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Integra LifeSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
